Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $1.32 Million - $1.54 Million
24,000 Added 33.9%
94,800 $5.57 Million
Q3 2019

Oct 29, 2019

BUY
$42.77 - $50.71 $855,400 - $1.01 Million
20,000 Added 39.37%
70,800 $3.59 Million
Q2 2019

Aug 02, 2019

BUY
$44.62 - $49.34 $892,400 - $986,800
20,000 Added 64.94%
50,800 $2.3 Million
Q1 2019

May 01, 2019

BUY
$45.12 - $53.8 $1.39 Million - $1.66 Million
30,800 New
30,800 $1.47 Million
Q4 2018

Feb 04, 2019

SELL
$48.76 - $63.23 $1.42 Million - $1.85 Million
-29,200 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
$55.19 - $62.25 $44,152 - $49,800
-800 Reduced 2.67%
29,200 $1.81 Million
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $1.8 Million - $1.96 Million
30,000
30,000 $1.84 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Advanced Asset Management Advisors Inc Portfolio

Follow Advanced Asset Management Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advanced Asset Management Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advanced Asset Management Advisors Inc with notifications on news.